Iron Replacement Therapy with Oral Ferric Maltol: Review of the Evidence and Expert Opinion.

ABSTRACT: Iron deficiency is the most common cause of anemia globally and is frequently reported in patients with underlying inflammatory conditions, such as inflammatory bowel disease (IBD) and chronic kidney disease (CKD). Ferric maltol is a new oral iron replacement therapy designed to optimize iron absorption while reducing the gastrointestinal adverse events associated with unabsorbed free iron. Ferric maltol has been studied in clinical trials involving almost 750 adults and adolescents with iron-deficiency anemia associated with IBD, CKD, and other underlying conditions, and it has been widely used in clinical practice. It is approved for the treatment of adults with iron deficiency with or without anemia, independent of the underlying condition, and is commercially available in Europe and th

SUBMITTER: Schmidt C 

PROVIDER: S-EPMC8509126 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature